DOCS logo

DOCS
Doximity Inc

4,054
Mkt Cap
$4.61B
Volume
2.69M
52W High
$76.51
52W Low
$20.55
PE Ratio
20.98
DOCS Fundamentals
Price
$24.98
Prev Close
$24.44
Open
$24.93
50D MA
$24.19
Beta
1.22
Avg. Volume
3.08M
EPS (Annual)
$1.11
P/B
4.72
Rev/Employee
$687,227.71
$10,772.83
Loading...
Loading...
News
all
press releases
Doximity (DOCS) Outperforms Broader Market: What You Need to Know
In the latest trading session, Doximity (DOCS) closed at $24.66, marking a +2.71% move from the previous day.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31...
Business Wire·9d ago
News Placeholder
Wall Street Analysts Think Doximity (DOCS) Is a Good Investment: Is It?
The average brokerage recommendation (ABR) for Doximity (DOCS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks·9d ago
News Placeholder
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine?
OptimizeRx rides AI-driven engagement gains, as oncology pilots scale to multi-brand deals and med tech traction fuels rising enterprise investment momentum.
Zacks·9d ago
News Placeholder
Doximity (NYSE:DOCS) Stock Rating Upgraded by Zacks Research
Zacks Research upgraded shares of Doximity from a "strong sell" rating to a "hold" rating in a research note on Tuesday...
MarketBeat·9d ago
News Placeholder
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform
HIMS is building a data-driven care platform, adding Labs and multi-cancer testing to personalize treatment via continuous monitoring insights.
Zacks·11d ago
News Placeholder
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know
Doximity (DOCS) reached $24.39 at the closing of the latest trading day, reflecting a -1.3% change compared to its last close.
Zacks·12d ago
News Placeholder
Doximity (NYSE:DOCS) Shares Gap Down - Time to Sell?
Doximity (NYSE:DOCS) Shares Gap Down - Here's Why...
MarketBeat·12d ago
News Placeholder
Doximity, Inc. (NYSE:DOCS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Doximity, Inc. (NYSE:DOCS - Get Free Report) have received a consensus rating of "Moderate Buy" from the twenty-two analysts that are covering the firm, MarketBeat.com reports. One...
MarketBeat·12d ago
News Placeholder
OPRX Trades at a Discount to Industry: How to Approach the Stock Now?
OptimizeRx trades at a steep discount to peers, but strong AI-driven growth, rising cash flow and DAAP traction look encouraging.
Zacks·15d ago
<
1
2
...
>

Latest DOCS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.